GetTopicDetailResponse(id=27391083236a, topicName=樂普生物, introduction=樂普生物, content=鼻咽癌 晚期鼻咽癌 MRG003 樂普生物, image=null, comments=0, allHits=966, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Dec 07 13:43:14 CST 2023, time=2023-12-07, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=484087, tagList=[TagDto(tagId=484087, tagName=樂普生物)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2173491, encodeId=e7ef21e349178, content=<a href='/topic/show?id=c3f910342343' target=_blank style='color:#2F92EE;'>#鼻咽癌#</a> <a href='/topic/show?id=654f59900d9' target=_blank style='color:#2F92EE;'>#晚期鼻咽癌#</a> <a href='/topic/show?id=21b210832265' target=_blank style='color:#2F92EE;'>#MRG003#</a> <a href='/topic/show?id=27391083236a' target=_blank style='color:#2F92EE;'>#樂普生物#</a>, objectTitle=樂普生物ADC藥物MRG003治療復(fù)發(fā)/轉(zhuǎn)移性鼻咽癌獲美FDA授予快速通道資格，86.2%疾病控制率！, objectType=article, longId=804088, objectId=9057804088bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231204/dc308ed07bae40cf98b127c1b36359c6.jpg, objectUrl=/article/show_article.do?id=9057804088bf, replyNumber=0, likeNumber=167, createdTime=2023-12-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=9057804088bf, moduleTitle=樂普生物ADC藥物MRG003治療復(fù)發(fā)/轉(zhuǎn)移性鼻咽癌獲美FDA授予快速通道資格，86.2%疾病控制率！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9057804088bf)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2023-12-07發(fā)表于威斯康星
